These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27481185)

  • 1. Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases.
    Rutz S; Eidenschenk C; Kiefer JR; Ouyang W
    Cytokine Growth Factor Rev; 2016 Aug; 30():1-17. PubMed ID: 27481185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
    Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
    PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RORγt protein modifications and IL-17-mediated inflammation.
    Kumar R; Theiss AL; Venuprasad K
    Trends Immunol; 2021 Nov; 42(11):1037-1050. PubMed ID: 34635393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present).
    Sun N; Guo H; Wang Y
    Expert Opin Ther Pat; 2019 Sep; 29(9):663-674. PubMed ID: 31403347
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibiting RORγt/Th17 axis for autoimmune disorders.
    Isono F; Fujita-Sato S; Ito S
    Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease.
    Chuang HC; Tsai CY; Hsueh CH; Tan TH
    Sci Adv; 2018 Sep; 4(9):eaat5401. PubMed ID: 30214937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
    Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
    Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA‑mediated knockdown of T‑bet and RORγt contributes to decreased inflammation in pre‑eclampsia.
    Wang J; Wen ZQ; Cheng XY; Mei TY; Chen ZF; Su LX
    Mol Med Rep; 2017 Nov; 16(5):6368-6375. PubMed ID: 28849203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.
    Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M
    J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RORs in autoimmune disease.
    Chang MR; Rosen H; Griffin PR
    Curr Top Microbiol Immunol; 2014; 378():171-82. PubMed ID: 24728598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1.
    Wu Q; Nie J; Gao Y; Xu P; Sun Q; Yang J; Han L; Chen Z; Wang X; Lv L; Tsun A; Shen J; Li B
    Sci Rep; 2015 Nov; 5():16355. PubMed ID: 26549310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003.
    Sasaki Y; Odan M; Yamamoto S; Kida S; Ueyama A; Shimizu M; Haruna T; Watanabe A; Okuno T
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3549-3553. PubMed ID: 30301676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel isoform of the orphan receptor RORγt suppresses IL-17 production in human T cells.
    Rauen T; Juang YT; Hedrich CM; Kis-Toth K; Tsokos GC
    Genes Immun; 2012 Jun; 13(4):346-50. PubMed ID: 22237416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.
    Huh JR; Leung MW; Huang P; Ryan DA; Krout MR; Malapaka RR; Chow J; Manel N; Ciofani M; Kim SV; Cuesta A; Santori FR; Lafaille JJ; Xu HE; Gin DY; Rastinejad F; Littman DR
    Nature; 2011 Apr; 472(7344):486-90. PubMed ID: 21441909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
    Ding Q; Zhao M; Yu B; Bai C; Huang Z
    PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.
    Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J
    Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.